SCHEMBL13802481

SCHEMBL13802481

CNC(=O)c1cc([N+](=O)[O-])ccc1NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.53
GAA P10253 3/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
RAB9A P51151 2/20 0.53
MITF O75030 1/20 0.51
P2RX1 P51575 1/20 0.50
TMPRSS4 Q9NRS4 1/20 0.50
PIN1 Q13526 2/20 0.48
NPC1 O15118 1/20 0.48
ATM Q13315 1/20 0.48
ALDH1A1 P00352 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
KDM4E B2RXH2 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
IDO1 P14902 1/20 0.44
PKM P14618 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4209269 0.87 MAPT (0.70) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL13802487 0.87 MITF (0.67) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL4214830 0.87 MAPT (0.53) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL13802482 0.86 MAPT (0.52) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL13802486 0.83 MAPT (0.56) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL13802476 0.79 PIN1 (0.49) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL4211539 0.78 MAPT (0.72) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL7428879 0.76 KMT2A (0.58) MAPTGAAKMT2AMEN1RAB9A
SCHEMBL18150551 0.74 RORC (0.52) MAPTGAAKMT2AMEN1P2RX1
SCHEMBL4207992 0.72 MAPT (0.74) MAPTGAAKMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090155903-A1 PHARMACEUTICAL COMPOSITION AND METHOD MYRIAD GENETICS, INCORPORATED (US) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090155903-A1 PHARMACEUTICAL COMPOSITION AND METHOD APP, PSEN2, PSEN1 MAPT 6/4885GAA 133/4885KMT2A 2408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.